PTGS2 and type 1 diabetes mellitus: We presently review the effects of PTGS2/COX2-PGE2 cascade in different inflammatory contexts, focusing on pancreatic beta cells subjected to T1DM conditions and discuss its potential exploitation as therapeutic target for the autoimmune pathology.